Apeptico Forschung und Entwicklung Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $656K
Latest Deal Amount
  • Investors
  • 5

Apeptico Forschung und Entwicklung General Information

Description

Developer of peptide-based products intended to target and treat chronic and life-threatening diseases. The company's products are made by concentrating on synthetically produced protein structures to avoid general risks associated with gene and cell technologies, enabling doctors to significantly reduce cost and shorten time to market.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Mariahilfer Straße 136
  • Top 1.15
  • Vienna, 1150
  • Austria
+43 0664 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Apeptico Forschung und Entwicklung Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 08-Jul-2013 $656K 00.000 Completed Generating Revenue
3. Early Stage VC 16-May-2012 00.000 Completed Startup
2. Early Stage VC (Series A) 05-Aug-2010 $3.87M $5.23M Completed Startup
1. Seed Round 29-May-2009 $1.37M $1.37M Completed Startup
To view Apeptico Forschung und Entwicklung’s complete valuation and funding history, request access »

Apeptico Forschung und Entwicklung Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of peptide-based products intended to target and treat chronic and life-threatening diseases. The company's pr
Drug Discovery
Vienna, Austria
00.000
0000000000 00.000

00000000

. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo c
0000000000000
San Diego, CA
000 As of 0000
00000
000000000 - 00000

0000000

didunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000 000000000
Toronto, Canada
0 As of 0000
00.000
000 0000-00-00
000000&0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Apeptico Forschung und Entwicklung Competitors (62)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sorrento Therapeutics Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
0000000 0000000000 Formerly VC-backed Toronto, Canada 0 00.000 000000&0 00.000
000000000 00000000 Venture Capital-Backed Austin, TX 00 000.00 0000000000 0 000.00
0000 000000000000 Venture Capital-Backed San Diego, CA 0 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Boston, MA 0 00000 000000000 00000
You’re viewing 5 of 62 competitors. Get the full list »

Apeptico Forschung und Entwicklung Executive Team (4)

Name Title Board Seat Contact Info
Bernhard Fischer Chief Executive Officer & Managing Director
Hermann Mascher Executive
Rudolf Lucas Scientific Advisor
You’re viewing 3 of 4 executive team members. Get the full list »

Apeptico Forschung und Entwicklung Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
The Austrian Research Promotion Agency Government 000 0000 000000 0
BioBac Angel Group Minority 000 0000 000000 0
Venture Plus Venture Capital Minority 000 0000 000000 0
INiTS Universitäres Gründerservice Accelerator/Incubator Minority 000 0000 000000 0
The BioScience Ventures Group Venture Capital Minority 000 0000 000000 0
To view Apeptico Forschung und Entwicklung’s complete investors history, request access »